#Canada #Vancouver #Investment #financing #Else Nutrition

Else Nutrition Secures $1.28 Million in Funding

Date: November 24, 2025
Location: Vancouver, BC

Else Nutrition Holdings Inc., a company specializing in plant-based nutrition products, has recently announced the initiation of a notable funding agreement aimed at generating gross proceeds of up to $1.28 million. This financial arrangement, made with Lind Global Fund III LP, opens doors for both immediate funding and future investment opportunities to bolster the company's operational capacity and market presence.

Details of the Financing Agreement

Under the new agreement, Else will issue an initial convertible security with a face value of $420,000. After accounting for the original issue discount and relevant fees, the company anticipates receiving approximately $337,750 in net funds. The initial convertible security has a maturity date of 24 months and is convertible into common shares of Else under specified conditions. Lind Global Fund III LP, a reputable New York-based institutional fund manager, will have the option to convert 1/20th of the face value each month beginning four months after the issuance. The conversion price will be calculated based on the greater of 80% of the five-day volume-weighted average price of Else's shares before each conversion or the average price minus maximum permitted discounts by the Toronto Stock Exchange.

Further, the company retains the right to repay the outstanding face value in cash after 180 days, allowing for strategic flexibility. Should Else exercise this buy-back option, Lind will be enabled to convert up to one-third of the convertible security's face value into shares.

Additionally, the agreement includes provisions for subsequent funding rounds, known as Second, Third, and Fourth Draws, each potentially providing up to $310,000 through further convertible securities. Alongside these securities, each round will involve detached warrants to purchase additional shares. The first batch of warrants will be issued based on calculations derived from the total dollar amount of each draw relative to the share price before the draw's closure.

Strategic Use of Proceeds

The proceeds from this funding arrangement are earmarked primarily for enhancing production and general operational expenditures. With heightened capacity and resources, Else aims to continue developing its innovative plant-based formulas that cater to infants, toddlers, and children, increasing its footprint in the competitive nutrition industry. Acknowledging the incredible demand for non-dairy alternatives, the company is focusing on expanding its product range and distribution channels.

Market Response and Future Outlook

The Toronto Stock Exchange (TSX) has provisionally approved the company's entry into this funding agreement, along with the issuance of the convertible securities and the associated warrants. Up to 10,582,354 shares could be conditionally listed under TSX private placement rules. The successful execution of this agreement not only strengthens Else’s financial position but also lays the groundwork for potential strategic growth initiatives.

As a pioneer in plant-based nutrition, Else has received accolades and recognition within the industry, such as the 2017 Best Health and Diet Solutions award at Milan’s Global Food Innovation Summit and being named the #1 Best Seller on Amazon in its category during the Fall of 2020. With a strong foundation of market support and acclaimed products, this latest funding effort is poised to enhance its development trajectory further.

Conclusion

Else Nutrition Holdings Inc. continues to demonstrate a commitment to advancing the availability of clean, innovative nutrition alternatives. With this significant funding agreement, the company is not only set to strengthen its market position but also fulfill its vision of providing parents and caregivers with superior nutrition options that prioritize health and sustainability.

For more details about Else Nutrition's product offerings and their mission, visit www.elsenutrition.com.